Navigation Links
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
Date:4/26/2009

/Ribavirin (IR) Therapy: Final Results of the EPIC3 Cirrhosis Maintenance Trial(1)

The large EPIC3 clinical study program includes a prospective trial designed to assess the efficacy and tolerability of long-term, low-dose maintenance therapy with PEGINTRON 0.5 mcg/kg/week in patients who previously failed treatment with any alfa-interferon plus ribavirin combination therapy. A total of 631 patients were randomized to PEGINTRON or observational control. Of these, 454 patients were from the retreatment study portion of the EPIC3 program and 172 were direct enrollers into the maintenance study. The primary efficacy measure for the study was time to development of first clinical event, defined as liver decompensation (variceal bleeding, Child-Pugh class C, grade 2 or higher hepatic encephalopathy, ascites requiring therapeutic paracentesis and/or additional therapy), development of hepatocellular carcinoma (HCC), liver transplantation or death. All events other than transplantation and death were adjudicated by an independent committee of experts blinded to the study arm. The secondary efficacy analyses included time to disease progression, including additional events of Child-Pugh class B, emergence of varices and enlargement of pre-existing varices requiring additional therapy.

In the primary efficacy analysis, 36 patients in the control arm and 27 in the treatment arm had clinical events (P=0.14), a non-statistically significant difference. However, in the secondary efficacy analysis there were 87 clinical events in the control arm and 63 in the treatment arm (P=0.01), a statistically significant difference. The main events causing the difference on secondary analysis were emergence or enlargement of varices (43 control vs. 16 treatment). In patients with pre-existing esophageal varices (n=82) there were significantly more events (n=14) in the observation arm compared to the treatment arm (n=4) (P=0.01). Overall the safet
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CAESAREA, Israel , July 10, 2014 /PRNewswire/ ... Dario™ Diabetes Management Solution, today announced the appointment ... an independent member of its Board of Directors. ... of legal and business experience to LabStyle as ... director, and legal and corporate governance expert. He ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)... /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from ... China,s orthopedic instrument industry has seen ... rising from 3.28 billion yuan in 2006 to 9.85 ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... Solutions, Inc. (OTCQB: VHSLD) announced that it will begin ... Financial Industry Regulatory Authority has approved a change in ... ticker change has gone into effect for the trading ... the "D" will be removed from the ticker symbol ...
... Henry Schein, Inc., (NASDAQ: HSIC ), the ... practitioners, announced today that Stanley M. Bergman, Chairman ... the Company,s Executive Vice President and Chief Financial Officer, will ... on May 4, 2011. The conference is being held at ...
Cached Medicine Technology:Vertical Health Solutions to Begin Doing Business as OnPoint Medical Diagnostics and Announces Completion of Symbol Change 2Henry Schein to Present at Deutsche Bank 36th Annual Health Care Conference 2
(Date:7/10/2014)... (PRWEB) July 10, 2014 A ... program that gets clients off to a great start ... can believe in, has launched a new Eating Disorders ... The new section highlights:, , Different ... Statistic Manual of Mental Disorders (DSM-IV), including anorexia nervosa, ...
(Date:7/10/2014)... not nurture, may play the bigger role in the ... "As is the case in humans, genes matter ... William Hopkins of the Yerkes National Primate Research Center ... journal Current Biology . The findings might ... humans, Hopkins, team said. According to the researchers, ...
(Date:7/10/2014)... -- Men who have a vasectomy may be at ... suggests. But the risk is comparatively small, the ... study said more research is needed to determine if ... study, Harvard researchers analyzed data from more than 49,400 ... in 1986. During that time, 6,023 cases of prostate ...
(Date:7/10/2014)... 200 experts on aggression, who research issues ranging from ... 21st World Meeting of the International Society for Research ... 15-19. , Georgia State University is hosting the prestigious ... alternating continents. , "We are excited to be bringing ... which will help produce fresh ideas about the causes, ...
(Date:7/10/2014)... The U.S. Department of Health and Human Services (HHS) ... Case Medical Center Seidman Cancer Center totaling $4.7 million ... care for patients with complex cancer. , Titled ... model developed at UH to enhance care for adult ... need for high health care utilization. , ...
Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:Like Humans, Chimps' Smarts May Rely on Genes 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3
... to smoke, researchers say , WEDNESDAY, Sept. 9 (HealthDay News) ... cigarettes, "tricks" the brain into creating memory associations between environmental ... smokers miss lighting up when they are in a bar ... at Baylor College of Medicine are in the Sept. 10 ...
... , , NEW YORK, ... zooming by, it might just be one of the Vespa LX 50 ... are adding to their autumn Breast Cancer Awareness initiatives. Through a partnership ... Breast Cancer for Life: The Power of 15," Vespa USA ( ...
... , , , PRINCETON, ... from around the globe will converge at Las Vegas, Mandalay ... Conference & Expo. , , Produced ... will focus on "Thinking Forward - The Power of the ...
... , , , ... awarded $7,500 in grants to 15 nonprofit organizations in Pennsylvania and ... grants were awarded through Highmark,s Employee Volunteer Grant Program, which reinforces ... to help local organizations carry out their missions in the community. ...
... , , WASHINGTON, Sept. 9 ... joining Pioneering Healthier Communities (PHC), its signature initiative that brings together ... through environmental and policy change. PHC is funded through a ... , , Since its inception in ...
... VILLAGE, Nev., Sept. 9 PDL BioPharma, Inc. (PDL) (Nasdaq: ... president and chief executive officer, will present at the BioCentury NewsMakers ... September 16, 2009 at 11:00 a.m. Eastern Time. , , ... the conference call, go to the company,s website at ...
Cached Medicine News:Health News:Nicotine Plays Tricks on Brain: Study 2Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 2Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 3Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 4Health News:Vespa Pink Campaign Supports Fight Against Breast Cancer 5Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 2Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 3Health News:Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations 2Health News:Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations 3Health News:Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations 4Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 2Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 3Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 4Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 5
Bone Curette, 160 mm...
Bone Currettes...
London Endocervical Curette is a stainless-steel curette for obtaining endocervical samples with minimal effort....
...
Medicine Products: